Endothelin receptor antagonism improves glucose handling, dyslipidemia, and adipose tissue inflammation in obese mice. - Rivera-Gonzalez O; Wilson NA; Coats LE; Taylor EB; Speed JS (Clinical science (London, England : 1979), 2021)